Health
Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection
--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patients with RSV infection --Preclinical research showed that ...
2023-05-08 16:50
2784
MEDICAL IP Is Creating Medical Digital Twins in Virtual Spaces, Powered by NVIDIA Omniverse
* MEDIP PRO, a real-time digital twin implementation solution based on medical imaging, is now connected to NVIDIA Omniverse * Maximize medical data scalability by sharing and simulating medical-imaging-based digital twins without time and space limitations SEOUL, South Korea and SANTA CLARA,...
2023-05-08 16:00
1959
Transcenta to Present Two Clinical Trial Progress at ASCO 2023
SUZHOU, China, May 8, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that two posters for c...
2023-05-08 14:55
2273
Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck
CAMBRIDGE, Mass. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Neuro3 Therapeutics (Neuro3), a biotechnology company focused on the discovery and development of innovative medicines for the treatment of central nervous system (CNS) diseases, announced today the signing of an exclusive, worldwide...
2023-05-08 14:00
1677
Bolivian and Taiwanese Experts Discuss the Latest Med-Tech Developments to Position Bolivia as a Leading hub in Robotic Neurosurgery
HSINCHU, May 8, 2023 /PRNewswire/ -- Medical experts from Bolivia and Taiwan recently joined forces to explore the latest technological advancements in surgical navigation robots and their potential to positionBolivia as a leader in robotic neurosurgery. During the largest robotic surgery online ...
2023-05-08 13:29
2477
Genomenon Recognized by Frost & Sullivan for Genomic Intelligence Solutions and Software for Pharma and Clinical Diagnostics Companies
Genomenon's unique blend of AI technology and expert scientific review delivers deep genomic insights into genetic drivers of rare diseases and cancer. SAN ANTONIO, May 8, 2023 /PRNewswire/ -- Frost & Sullivan today announced that it has awardedGenomenon with the 2023 Global Technology Innovation...
2023-05-08 12:01
2137
EirGenix's Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives
TAIPEI, May 8, 2023 /PRNewswire/ -- EirGenix, Inc. (6589.TT) announced on 28th of April that it has completed the phase 1 clinical trial (EGC101) of its second breast cancer biosimilar EG1206A inEurope. Comparing EG1206A to Roche's Perjeta® US and EU, results of the clinical data analysis show th...
2023-05-08 10:00
2251
World Lupus Federation Urges Global Community to Raise Lupus Awareness on May 10 for World Lupus Day 2023
Lupus awareness tools, facts and resources available at WorldLupusDay.org/tool-kit WASHINGTON, May 8, 2023 /PRNewswire/ -- World Lupus Day was established to take place onMay 10 by the World Lupus Federation (WLF) to unite lupus groups around the world during Lupus Awareness Month and call atten...
2023-05-08 08:00
2519
Innovent Updates the Results from the ORIENT-31 Study of Sintilimab Plus Chemotherapy With or Without Bevacizumab in Patients with EGFR-TKI failed EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Lancet Respiratory Medicine
ROCKVILLE, Md. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-05-08 08:00
4107
Duoning Biotech Celebrates Ground Breaking for Its Global Headquarters
SHANGHAI, May 8, 2023 /PRNewswire/ -- On May 6th, the "2023 Commencement Ceremony for Major Industrial Projects in Fengxian and for Duoning's Global Headquarters and Industrialization Base" was held grandly in the Biotechnology Park. Leaders of the Fengxian district, representatives of the Orient...
2023-05-08 08:00
2547
Innovent Announces First Participant Dosed in Phase 3 Study (RESTORE) of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Eye Disease
ROCKVILLE, MD. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-05-08 08:00
3465
BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701
HANGZHOU, China, May 7, 2023 /PRNewswire/ -- Bliss Biopharmaceutical (Hangzhou) Co., Ltd, ("BlissBio") a clinical-stage biopharmaceutical company developing differentiated antibody-drug conjugate (ADC) therapeutics, announced a clinical trial collaboration agreement with option for strategic coll...
2023-05-08 07:00
2249
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study, including Japanese Sites
MELBOURNE, Australia and KYOTO, Japan, May 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injectio...
2023-05-08 05:00
2457
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study
MELBOURNE, Australia, May 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injection)[1] for the Pha...
2023-05-08 05:00
5487
NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE
* Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST * QINLOCK significantly reduced the risk of disease progression or death by 85% and showed clinically meaningful overall survival in theINVICTUS Phase 3 Study1,2 ...
2023-05-08 04:00
1934
Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted
SUZHOU, China, May 6, 2023 /PRNewswire/ -- Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance by the FDA. GEN6050 is an in vivo base editing drug that targets exon 50 skipping in the Duchenne muscular...
2023-05-06 21:00
4732
Empowering Innovation to the Global Market with Acro Certify
TOKYO, May 6, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. It is an immense logistical and financial challenge that makes or breaks a company, despite the product itself. For companies in that awkward, transitional stage from start-up company to a m...
2023-05-06 10:18
4483
Empowering Innovation to the Global Market with Acro Certify
NEWARK, Del., May 5, 2023 /PRNewswire/ -- For many companies, entering the global market is a daunting challenge. These obstacles can come in various forms. Sometimes the problem is finding the right target customer base or establishing an appropriate quality management system and shipping logist...
2023-05-06 10:18
4894
CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
China recorded unprecedented improvement in its API manufacturing score in the
2022 end of year CPHI Survey
SHANGHAI, May 6, 2023 /PRNewswire/ -- CPHI & PMEC China
2023-05-06 10:13
3427
Vice President of Tencent HealthCare Zhang Yu: Create the "flywheel" of software development effectiveness and efficiency to drive continuous innovation in healthcare
BEIJING, May 5, 2023 /PRNewswire/ -- The digital era has ushered rapid changes in software development philosophy and process, as well as technologies and tools. For healthcare, the digital transformation of the industry allows for rapid response to major public health emergencies, stable operati...
2023-05-05 21:10
2512
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 297 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6933
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
6853
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
2024-09-23 13:37
6316
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
5639
Sobot Reflects on its Partnership with Lilith Games on Lilith's 11th Anniversary
2024-09-24 10:00
5543
